Results 71 to 80 of about 2,690,172 (163)

High Awareness, Low Clarity: Knowledge of the Australian Capital Territory's Multi‐Drug Decriminalisation Reform Among People Who Use Illicit Drugs

Drug and Alcohol Review, Volume 45, Issue 6, September 2026.
ABSTRACT Introduction In October 2023, the Australian Capital Territory became the first Australian jurisdiction to decriminalise possession of small quantities of multiple illicit drugs by law, introducing an alternative, legislated pathway enabling police to divert individuals to a health education and information session or issue a $100 expiation ...
Rachel Sutherland, Connor Graham, Caitlin Elizabeth Hughes, Anna Olsen, Chris Gough, Cate King, Amy Peacock   +6 more
wiley   +1 more source

Lysergic acid diethylamide pretreatment prolongs brain-stimulation induced neural activity changes

Brain Stimulation
A leading theory for how psychedelics are able to produce robust clinical improvement and preclinical behavioral changes is that psychedelics act through neuroplastic mechanisms to induce lasting structural and functional alterations in neural circuits ...
Lucas L. Dwiel, Mackenzi L. Prina, Elise M. Bragg, Matthew Company, Lucky L. Drucker, Laetitia R. Reduron, Bryan W. Luikart, Wilder T. Doucette   +7 more
doaj   +1 more source

The Serotonin 2B (5‐HT2B) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression

Clinical Pharmacology &Therapeutics, Volume 120, Issue 2, Page 345-356, August 2026.
Major depressive disorder (MDD) and treatment‐resistant depression (TRD) remain leading causes of disability, providing the impetus for receptor‐level treatment strategies beyond monoamine reuptake. The serotonin 5‐HT2B receptor (5‐HT2BR) is uniquely positioned at the interface of central‐antidepressant mechanisms and peripheral cardiac risks.
Gia Han Le, Sabrina Wong, Danica E. Johnson, Diana K. Orsini, Yang Jing Zheng, Kayla M. Teopiz, Christine E. Dri, Joshua D. Rosenblat, Roger S. McIntyre   +8 more
wiley   +1 more source

Correction to Total Synthesis of Lysergic Acid

, 2016
Correction to Total Synthesis of Lysergic ...
Tohru Fukuyama (1508317), Satoshi Yokoshima (1575334), Satoshi Umezaki (1754827)   +2 more
core   +1 more source

sj-pptx-1-jop-10.1177_02698811221104641 – Supplemental material for Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice

, 2022
Supplemental material, sj-pptx-1-jop-10.1177_02698811221104641 for Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice by Lauri V Elsilä, Juliana Harkki, Emma Enberg ...
Anni-Maija Linden (206851), Alvar Martti (12876824), Juliana Harkki (12876818), Esa R Korpi (12876827), Lauri V Elsilä (12876815), Emma Enberg (12876821)   +5 more
core   +1 more source

Psychoactive Substance Use and Associated Factors Among Adolescent Commercial Tricycle Riders in Tamale, Ghana: A Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background Psychoactive substance use (PSU) has become a major public health concern. Many countries are alarmed by the increasing use of psychoactive substances among adolescents, and Ghana is not an exception. Aim The study assessed psychoactive substance use among adolescent commercial tricycle riders of Tamale, Northern Region, Ghana ...
Yaa Nyarko Adjeso, Zaratu Bimonka Alhassan, Joseph Lasong   +2 more
wiley   +1 more source

Synthesis of N‐Benzyl o‐Methoxy Phase I Metabolites for Use as Liquid Chromatography‐Quadrupole Time of Flight Standards

ChemistrySelect, Volume 11, Issue 30, 10 August 2026.
A novel synthetic method for three phase I o‐desmethyl NBOMe metabolites bromo‐ (3a) and iodo‐ (13b) and chloro‐ analogue (13c) was developed. LC‐QToF analysis confirmed that the synthetic standards matched the major peaks observed in urine sample screens for each of the respective halogen‐substituted metabolites indicating that the synthesised ...
Jordan Spangler, Martin R. Johnston, Peter Stockham   +2 more
wiley   +1 more source

Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials

Frontiers in Psychiatry, 2020
Lysergic acid diethylamide (LSD) was studied from the 1950s to the 1970s to evaluate behavioral and personality changes, as well as remission of psychiatric symptoms in various disorders.
Juan José Fuentes, Francina Fonseca, Francina Fonseca, Francina Fonseca, Matilde Elices, Matilde Elices, Magí Farré, Magí Farré, Marta Torrens, Marta Torrens, Marta Torrens   +10 more
doaj   +1 more source

sj-docx-1-jop-10.1177_02698811221099650 – Supplemental material for Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)

, 2022
Supplemental material, sj-docx-1-jop-10.1177_02698811221099650 for Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD) by Emma I Kopra, Jason A Ferris, James J Rucker, Benjamin ...
Jason A Ferris (12385796), Benjamin McClure (12855027), Allan H Young (9559350), Emma I Kopra (12385793), Adam R Winstock (5196926), James J Rucker (9908841), Caroline S Copeland (12855030)   +6 more
core   +1 more source

Lysergic Acid Diethylamide (LSD) and mystical experiences

, 2016
Lysergic acid diethylamide (LSD) is the best-known drug of a subtype of hallucinogens, commonly referred to as psychedelics. LSD is by far the most potent psychedelic and one of the most potent psychoactive substances ever discovered.
Michael Lyvers, Lyvers, Michael; id_orcid   +1 more
core   +1 more source